Hepatitis B virus with a G145R mutation in the small surface protein is considered the quintessential immune escape mutant because it frequently is found in vaccinated individuals with breakthrough infections and liver transplant recipients under anti-hepatitis B surface antigen (HBsAg) immunoglobulin prophylaxis. Nowadays the prevalence of the variant progressively increases. However, because spread of a virus depends not only on immune pressure but also on the viral phenotype, we investigated the biologic properties of the G145R variant. The G145R mutation was introduced into wild-type (Wt) virus genome by in vitro mutagenesis. After transfection into human hepatoma cells, the DNA, RNA, and protein synthesis and viral secretion ability of the mutant were studied. Furthermore, cotransfection studies were performed with the G145R variant and a Wt virus S-protein expressing construct and vice versa. Production and stability of viral messenger RNAs (mRNAs), DNA, and proteins were not affected by the G145R mutation. In contrast, secretion of mutant virions was reduced significantly. Only 20% of virions were found in the medium of G145R variant-transfected cells compared with Wt virus. Furthermore, mutant virions were more sensitive to detergent treatment suggesting a diminished stability. In cotransfection studies, Wt virus S-protein rescued secretion of mutant virions, whereas mutant S-protein had a transdominant negative effect on secretion of Wt virus. Both mechanisms may support persistence of the defective mutant in a mixed population with Wt virus. In conclusion, the significant defect of the G145R mutant for secretion of infectious virions and the diminished stability of mutant virions may limit global spread of the mutant. H epatitis B virus (HBV) exhibits a mutation rate more than 4 orders of magnitude higher than that of other DNA viruses. 1 Naturally occurring variants may accumulate over time if they have a survival benefit over wild-type (Wt) virus, such as a higher ability to replicate DNA, an enhanced secretion ability, an increased infectivity or stability of virions, and so forth. In addition, certain variants may be selected under immune pressure or therapy with antiviral drugs.Nowadays, immune-escape variants that emerge under active and/or passive vaccination and are responsible for vaccination-breakthrough infections are of particular clinical relevance. Several such mutants carrying single or multiple amino acid substitutions in the major antigenic region of the virus, the a-determinant of the small surface protein, have been described. [2][3][4] The mutant by far most frequently detected all over the world in vaccinated individuals and liver transplant recipients treated with monoclonal or polyclonal anti-hepatitis B surface antigen (HBsAg) hyperimmunoglobulin carries a glycine to arginine substitution at amino acid position 145 (G145R). 3,[5][6][7][8][9][10][11] There is no doubt that despite selection of immuneescape variants, vaccination programs have so far been highly effective in reduci...